The Next Wave of ADCs Could Treat Evasive Solid Tumors

[cafead]

via Advances in antibody-drug conjugates, including novel payloads and new targets, will be featured at the American Association for Cancer Research's annual conference, taking place this week in San Diego, where companies, including Elevation Oncology and Tubulis, will present new data from their respective programs.

article source